MHRA reviewing chloramphenicol eye drops safety as service is scrapped
The MHRA is “urgently” reviewing the evidence around the safety of chloramphenicol eye drops in children under two years, after an EMA update prompted cessation of some services.
The MHRA is “urgently” reviewing the evidence around the safety of chloramphenicol eye drops in children under two years, after an EMA update prompted cessation of some services.